Answers are grounded in this paper and cite their sources.
Investigates chemical modifications and devitrification in phosphate glasses, indicating structural impacts.
This study examines the chemical modification and devitrification of phosphate-based oxide glasses in the system yAl2O3-(1-y)[0.5MoO3-0.5P2O5] for varying aluminium contents (0 ≤ y ≤ 30 mol%), utilizing various physical and chemical methods. This investigation utilized IR and NMR spectroscopic techniques to explore the relationship between structure, composition, and characteristics of glasses with the composition yAl2O3-(1-y)[0.5MoO3-0.5P2O5 (0 ≤ y ≤ 30 mol%)]. Findings indicated the glasses' chemical durability, revealing insights into their dissolution mechanisms. Comparative dissolution experiments suggested that reduced dissolution rates at higher Al2O3 concentrations may result from the rearrangement of P=O bonds and network cross-linking. Structural changes in glasses have been analysed through NMR and infrared spectroscopy, highlighting the impact of the O/P ratio on their properties. The introduction of Al2O3 to glasses with O/(P+Mo) > 4 causes some bridging oxygen atoms in pyrophosphate units to depolymerize, resulting in isolated orthophosphate groups. The devitrification of oxide glasses yAl2O3-(1-y)[xMoO3-(1-x)P2O5] has been examined, with y ranging from 0 to 30 and x set at 50 or 67 mol%. The diffractograms of recrystallized glasses rich in Al2O3 from the system yAl2O3-(1-y)[0.67MoO3-0.33P2O5], annealed below the melting point, show crystalline phases such as AIPO4, Al2(MoO4)3, and (MoO2)2P2O7, confirmed through XRD, NMR, IR, and ATD techniques.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: